A

Acrivon Therapeutics Inc
NASDAQ:ACRV

Watchlist Manager
Acrivon Therapeutics Inc
NASDAQ:ACRV
Watchlist
Price: 3.01 USD 31.44% Market Closed
Market Cap: 95m USD

Wall Street
Price Targets

ACRV Price Targets Summary
Acrivon Therapeutics Inc

Wall Street analysts forecast ACRV stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ACRV is 11.39 USD with a low forecast of 6.06 USD and a high forecast of 19.95 USD.

Lowest
Price Target
6.06 USD
101% Upside
Average
Price Target
11.39 USD
278% Upside
Highest
Price Target
19.95 USD
563% Upside
Acrivon Therapeutics Inc Competitors:
Price Targets
SVRA
Savara Inc
90% Upside
ACAD
ACADIA Pharmaceuticals Inc
11% Upside
TRDA
Entrada Therapeutics Inc
67% Upside
688382
InventisBio Co Ltd
68% Upside
KNSA
Kiniksa Pharmaceuticals Ltd
31% Upside
ADMA
ADMA Biologics Inc
43% Upside
AZT
Arcticzymes Technologies ASA
47% Upside
GILD
Gilead Sciences Inc
12% Upside

Revenue
Forecast

Revenue Estimate
Acrivon Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Acrivon Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Net Income
Forecast

Net Income Estimate
Acrivon Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-29%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ACRV's stock price target?
Price Target
11.39 USD

According to Wall Street analysts, the average 1-year price target for ACRV is 11.39 USD with a low forecast of 6.06 USD and a high forecast of 19.95 USD.

Back to Top